ImmuneAdvice GmbH

ImmuneAdvice GmbH is a pre-seed, preclinical radiopharmaceutical start-up based in Reutlingen, Germany, developing next-generation immune cell tracers (ICE-Ts) for PET imaging. Our lead candidate, CD4 ICE-T, non-invasively identifies the immune status of tumors – distinguishing “hot” from “cold” microenvironments – and enables early detection of resistance to immune checkpoint inhibitors (ICIs). By providing actionable insights into a patient’s response to immunotherapy, our ICE-Ts open the door to timely, personalized treatment adjustments, especially for melanoma and NSCLC patients – redefining cancer care.